Jump to content

Japanese Study Finds Merit In Drug No Longer Tested In U.S.


Recommended Posts

http://www.thecarolinachannel.com/healt ... etail.html

Japanese Study Finds Merit In Drug No Longer Tested In U.S.

POSTED: 11:43 a.m. EDT April 22, 2004

A study conducted in Japan found that a drug combination rejected as a cancer treatment in the United States can add years to the lives of people with early lung cancer.

The two-drug combination of uracil and tegafur, often called UFT, was given to 488 patients who had undergone surgery to have a cancerous tumor removed from their lungs. Researchers found that after five years, those patients who had larger cancers were more likely to live longer with the drug than without it.

After five years, 85 percent of those who received chemotherapy were alive.

The study is published in Thursday's issue of the New England Journal of Medicine.

UFT was not tested for lung cancer in the United States, but it was evaluated for treatment of colon cancer. Although the Food and Drug Administration rejected the application for approval of the drug, Japan and many European countries have approved its use.

Study Abstract

Distributed by Internet Broadcasting Systems, Inc. The Associated Press contributed to this report. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.